Here's What Analysts Think of ISRG.

Intuitive Surgical stock is trading -20.25% below its average target price of $368.32 after dropping -2.0% during today's afternoon session. Analysts are giving the large-cap Specialty Industrial Machinery company an average rating of buy and target prices ranging from $315.0 to $400.0 per share.

Intuitive Surgical's short interest — meaning the percentage of the share float that is being shorted — is lower than average at 0.9%. The stock's short ratio is 1.84. The company's insiders own 0.51% of its outstanding shares, which indicates a strong alignment between management and shareholder interests.

Another number to watch is the company's rate of institutional share ownership, which now stands at 87.6%. In conclusion, we believe there is positive market sentiment regarding Intuitive Surgical.

Institutions Invested in Intuitive Surgical

Date Reported Holder Percentage Shares Value
2023-06-30 Vanguard Group Inc 8% 29,671,911 $8,715,975,351
2023-06-30 Blackrock Inc. 8% 29,579,371 $8,688,792,189
2023-06-30 Price (T.Rowe) Associates Inc 5% 19,022,095 $5,587,645,202
2023-06-30 State Street Corporation 4% 14,810,625 $4,350,546,968
2023-06-30 FMR, LLC 2% 8,194,650 $2,407,137,424
2023-06-30 JP Morgan Chase & Company 2% 8,018,676 $2,355,445,942
2023-06-30 Capital World Investors 2% 7,510,586 $2,206,197,047
2023-06-30 Bank Of New York Mellon Corporation 2% 7,119,920 $2,091,440,865
2023-06-30 Alliancebernstein L.P. 2% 6,957,880 $2,043,842,426
2023-06-30 Geode Capital Management, LLC 2% 6,612,636 $1,942,428,729
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.